Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Aug 26, 2010 (rev. 1)

Premium

Kylin Therapeutics has appointed City of Hope researcher John Rossi to its scientific advisory board.

In addition to his position at the Beckman Research Institute of City of Hope, Rossi is an adjunct professor of biomedical sciences at the University of California, Riverside, and a co-founder of RNAi drug developer Dicerna Pharmaceuticals, where he also chairs the SAB.

He also serves on the SAB of Benitec.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.